Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesions.
The role of peripheral autonomic nerve failure in the development of medial arterial calcification is discussed controversially in the literature. In addition, the influence of medial wall calcification in the development of trophic foot lesions is still not fully understood. We have compared 28 diabetic patients with cardiac autonomic failure and/or decreased acetylcholine-induced sweat response with 22 diabetic patients without evidence of diabetic neuropathy and 27 healthy control subjects. A strong association was found between medial wall calcification and diminished heart rate variation (p.001) or diminished peripheral sweat response (p < 0.001). Only one subject in the control group exhibited a calcification of the tunica media in the lower limb. Medial calcinosis was accompanied by a significant rise of systolic ankle blood pressure (p < 0.05). In addition, there was a strong relationship between medial wall calcification and trophic foot lesions (p < 0.0001). Our results demonstrate a strong association between sympathetic C-fibre neuropathy and the development of medial wall calcification, as well as between calcification of the tunica media and trophic foot ulceration. Further investigation is necessary to determine whether there is a causal connection between medial arterial sclerosis and diabetic foot ulceration, or whether both are independent consequences of diabetic neuropathy.
Forst
T
T
University Hospital Mainz, Department of Internal Medicine and Endocrinology, Germany.
Pfützner
A
A
Kann
P
P
Lobmann
R
R
Schäfer
H
H
Beyer
J
J
D000109:Acetylcholine / Q000494:pharmacology; D000328:Adult; D001341:Autonomic Nervous System / Q000502:physiology; D002114:Calcinosis / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D003925:Diabetic Angiopathies / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D017719:Diabetic Foot / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D003929:Diabetic Neuropathies / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005528:Foot / Q000098:blood supply / Q000000981:diagnostic imaging; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D011859:Radiography; D013546:Sweating / Q000187:drug effects; D017779:Sympathetic Fibers, Postganglionic / Q000473:pathology*; D013564:Sympathetic Nervous System / Q000502:physiology
D000109:Acetylcholine